Introduction
Personalized medicine
The ABC of serum autoantibodies
Antinuclear antibodies (ANA)
Pattern | Related antigens | Related diagnosis |
---|---|---|
Nuclear | ||
Homogeneous | dsDNA, histones, nucleosomes | SLE, drug-induced lupus, JIA |
Speckled | hnRNP, U1RNP, Sm, SS-A, SS-B, RNAP-III, Mi-2, Ku | MCTD, SLE, SjS, DM, SSc/PM overlap |
Dense fine speckled | DFS70/LEDGF | Rare in SLE, SjS, SSc |
Fine speckled | SS-A, SS-B, Mi-2, TIF1γ, TIF1β, Ku, RNA helicase A, replication protein A | SjS, SLE, DM, SSc/PM overlap |
Large/coarse speckled | hnRNP, U1RNP, Sm, RNAP-III | MCTD, SLE, SSc |
Centromere | CENP-A/B | lcSSc, PBC |
Discrete nuclear dots | ||
Multiple nuclear dots | Sp100, PML protein, MJ/NXP-2 | PBC, SARD, PM/DM |
Few nuclear dots | p80-coilin, SMN | SjS, SLE, SSc, PM, asymptomatic subjects |
Nucleolar | ||
Homogeneous | PM/Scl75, PM/Scl100, Th/To, B23 nucleophosmin, nucleolin, No55/SC65 | SSc, SSc/PM overlap |
Clumpy | U3-snoRNP/fibrillarin | SSc |
Punctate | RNAP-I, hUBF/NOR-90 | SSc, SjS |
Nuclear envelope (NE) | ||
Smooth NE | Lamins A, B, C, or lamin associated proteins | SLE, SjS, seronegative arthritis |
Punctate NE | Nuclear pore complex proteins | PBC |
Pleomorphic | ||
PCNA-like | PCNA | SLE, other conditions |
CENP F-like | CENP-F | Cancer, other conditions |
Cytoplasmic | ||
Fibrillar | ||
Linear/actin | Actin, non-muscle myosin | MCTD, CH, cirrhosis, MG, CD, PBC, long-term HD |
Filamentous/microtubules | Vimentin, cytokeratin | Infections or inflammations, long-term HD, ALD, SARD, PsO, healthy subjects |
Segmental | α actinin, vinculin, tropomyosin | MG, CD, UC |
Speckled | ||
Discrete dots | GW182, Su/Ago2, Ge-1 | PBC, SARD, neurological and autoimmune conditions |
Dense fine speckled | PL-7, PL-12, ribosomal P proteins | ASS, PM/DM, SLE, juvenile SLE, neuroSLE |
Fine speckled | Jo1/histidyl-tRNA synthetase | ASS, PM/DM, lcSSc, IPE |
Reticular/AMA | PDC-E2/M2, BCOADC-E2, OGDC-E2, E1α subunit of PDC, E3BP/proteinX | PBC, SSc, rare in other SARD |
Polar/Golgi-like | Giantin/macrogolgin, golgin-95/GM130, golgin-160, golgin-97, golgin-245 | Rare in SjS, SLE, RA, MCTD, GPA, ICA, PCD, viral infections |
Rods and rings | IMPDH2, others | HCV patients post IFN/ribavirin, rare in SLE, Hashimoto’s and healthy controls |
Mitotic | ||
Centrosome | Pericentrin, ninein, Cep250, Cep110, enolase | Rare in SSc, RD, infections (viral and mycoplasma) |
Spindle fibers | HsEg5 | Rare in SjS, SLE, other SARD |
NuMA-like | Centrophilin | SjS, SLE, other |
Intercellular bridge | Aurora kinase B, CENP-E, MSA2, KIF14, MKLP1 | Rare in SSc, RD, malignancies |
Mitotic chromosomal envelope | Modified histone H3, MCA1 | Rare in DLE, CLL, SjS, PMR |
Anti-citrullinated peptide antibodies (ACPA)
Rare autoantibodies
Autoantibody | Prevalence (%) | Clinical associations | References |
---|---|---|---|
Anti-RNAP | 6–31 | dcSSc, renal crisis, malignancies | |
Anti-Scl70 | 10–40 | dcSSc, ILD, digital ulcers, cardiac involvement, malignancies | |
Anti-U3RNP | 5–8 | dcSSc, cardiomyopathy, myopathy, PAH, ILD, severe small bowel involvement | [89] |
Anti-U1RNP | 4–14 | lcSSc, PAH, overlap syndrome | [90] |
Anti-Ku | 1–3 | Muscle and joint involvement | [91] |
Anti-PM-Scl | 2–10 | myositis, arthritis, lung or kidney involvement and mechanic’s hands | [92] |
Anti-Th/To | 1–10 | lcSSc, PAH, ILD, puffy fingers, small bowel disease, hypothyroidism | [93] |
Anti-U11/U12RNP | 3 | ILD | [94] |
Autoantibody | Prevalence (%) | Clinical associations | References |
---|---|---|---|
Anti-ARS | 1–30 | Anti-synthetase syndrome | |
Anti-Mi2 | 10 | DM with typical skin lesions, mild disease | |
Anti-TIF1γ | 10–15 | Severe DM, malignancies | |
Anti-NPX2 | 1–5 | Severe DM, severe skin disease, malignancies | |
Anti-MDA5 | 15–20 | CADM, ILD, severe skin manifestations, poor prognosis | |
Anti-SAE | 1 | Amyopathic DM | [95] |
Anti-SRP | 5 | Necrotizing myopathy | [70] |
Anti-HMGCR | 6 | Necrotizing myopathy, proximal muscle weakness, elevated CK levels, prior statin use |
Autoantibody | Prevalence (%) | Clinical associations | References |
---|---|---|---|
Anti-Sm | 15 | LN, NPSLE, discoid SLE, photosensitivity | |
Anti-ribosomal P | 10 | NPSLE, renal and hepatic disorders, malar rash, oral ulcer and photosensitivity, blood–brain barrier permeation | |
Anti-La (SS-B) | 10–15 | Organ dysfunction (kidney, lung, liver) | |
Anti-Ki | 6–20 | Hashimoto’s thyroiditis, ITP, idiopathic ILD, PM/SSc overlap, synovitis, pericarditis, PAH, skin involvement and sicca symptoms | [102] |
Anti-histone | 21–81 | Drug-induced SLE | [103] |